China Compliance Probe Spreads To Novartis Alcon Unit
This article was originally published in PharmAsia News
Executive Summary
The 21st Century Business Herald has done it again, publishing another whistleblower account about corruption allegations in the China pharmaceutical industry, this time focusing on Novartis’ eye care unit Alcon.